Pub Date : 2025-01-01Epub Date: 2025-11-04DOI: 10.1159/000549416
Shashank Ghai, Ishan Ghai
Background: Pain, both acute and chronic, places a substantial burden on global healthcare systems. While conventional treatments may be limited in efficacy due to side effects, risk of dependency, or variable individual response, there is growing interest in mind-body complementary approaches. Yoga nidra (YGN) has emerged as a promising noninvasive intervention for pain management. However, a clear understanding of its efficacy remains limited. This systematic review and meta-analysis evaluated the effects of YGN on pain outcomes.
Methods: A literature search was conducted across seven databases and one trial database. Eligible studies included quantitative designs assessing the effects of YGN on pain. Methodological quality was evaluated using the Cochrane Risk of Bias tool for randomized controlled trials and the modified Downs and Black checklist for non-randomized studies. Random-effects meta-analyses were performed to estimate pooled effect sizes.
Results: Twelve studies, comprising 1,176 participants, were included. Between-group analyses revealed that YGN significantly reduced pain compared to passive comparators (Hedge's g: -2.05, p = 0.01), while comparisons with active comparators (g: -0.31, p = 0.53) showed no statistically significant differences. Within-group analyses indicated significant pain reduction following YGN (g: -2.01, p < 0.001). Subgroup comparisons of single versus multiple training sessions, as well as meta-regression analyses, revealed no significant dose-response relationship across intervention durations.
Conclusion: YGN shows potential in reducing pain intensity compared to passive control conditions, with notable within-group improvements following intervention. However, given the low methodological quality across the included studies, these effects should be interpreted cautiously, as the observed effects may represent inflated estimates. Despite these limitations, YGN demonstrates potential as a complementary approach for pain management, underscoring the need for high-quality, standardized research to establish its efficacy as a viable clinical intervention.
{"title":"Yoga Nidra and Pain: A between-, within-Group Meta-Analysis and Dose Response Meta-Regression.","authors":"Shashank Ghai, Ishan Ghai","doi":"10.1159/000549416","DOIUrl":"10.1159/000549416","url":null,"abstract":"<p><p><p>Background: Pain, both acute and chronic, places a substantial burden on global healthcare systems. While conventional treatments may be limited in efficacy due to side effects, risk of dependency, or variable individual response, there is growing interest in mind-body complementary approaches. Yoga nidra (YGN) has emerged as a promising noninvasive intervention for pain management. However, a clear understanding of its efficacy remains limited. This systematic review and meta-analysis evaluated the effects of YGN on pain outcomes.</p><p><strong>Methods: </strong>A literature search was conducted across seven databases and one trial database. Eligible studies included quantitative designs assessing the effects of YGN on pain. Methodological quality was evaluated using the Cochrane Risk of Bias tool for randomized controlled trials and the modified Downs and Black checklist for non-randomized studies. Random-effects meta-analyses were performed to estimate pooled effect sizes.</p><p><strong>Results: </strong>Twelve studies, comprising 1,176 participants, were included. Between-group analyses revealed that YGN significantly reduced pain compared to passive comparators (Hedge's g: -2.05, p = 0.01), while comparisons with active comparators (g: -0.31, p = 0.53) showed no statistically significant differences. Within-group analyses indicated significant pain reduction following YGN (g: -2.01, p < 0.001). Subgroup comparisons of single versus multiple training sessions, as well as meta-regression analyses, revealed no significant dose-response relationship across intervention durations.</p><p><strong>Conclusion: </strong>YGN shows potential in reducing pain intensity compared to passive control conditions, with notable within-group improvements following intervention. However, given the low methodological quality across the included studies, these effects should be interpreted cautiously, as the observed effects may represent inflated estimates. Despite these limitations, YGN demonstrates potential as a complementary approach for pain management, underscoring the need for high-quality, standardized research to establish its efficacy as a viable clinical intervention. </p>.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"495-521"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-03-21DOI: 10.1159/000543959
Giuseppe Di Lorenzo, Carlo Buonerba, Raffaele Baio, Eleonora Monteleone, Francesco Passaro, Antonio Tufano, Vittorino Montanaro, Vittorio Riccio, Ilaria Gallo, Francesca Cappuccio, Oriana Strianese, Roberta Zarrella, Anna Buonocore, Federica Monaco, Antonio Verde, Giovanni Riccio, Valentina Izzo, Federica Fortino, Ferdinando Costabile, Luca Scafuri
Background: The Mediterranean lifestyle is widely recognized for its role in reducing the risk of chronic diseases, including cardiovascular diseases, type 2 diabetes, and cancer. The PREVESMED questionnaire was developed to evaluate adherence to this lifestyle, integrating dietary and non-dietary behaviors. Unlike existing tools, PREVESMED incorporates underexplored elements such as eating pace, herbal tea consumption, and physical activity, providing a multidimensional approach to lifestyle assessment.
Methods: The validation of PREVESMED was carried out as part of a planned interim analysis using data collected from participants in the PREVES-ENERGY survey, a cross-sectional study targeting 1,000 adults aged 18 years and above. To assess the reliability of the PREVESMED scale, internal consistency was evaluated using Cronbach's alpha, ensuring an acceptable level of reliability. To investigate the relationships between lifestyle factors, individual questionnaire items, and adherence to Mediterranean lifestyle according to the PREVESMED scale, a correlation analysis was performed. Additionally, to identify significant predictors of better adherence, a multivariable linear regression model was utilized, highlighting key factors influencing adherence. Finally, an exploratory factor analysis (EFA) was conducted to reveal the underlying structure of the PREVESMED scale, identifying key dimensions and their contributions to the total variance.
Results: The cohort analyzed for the preliminary validation of the PREVESMED questionnaire consisted of 268 participants, in line with the protocol's planned sample size. Internal consistency analysis demonstrated acceptable reliability (Cronbach's alpha = 0.628). In the correlation analysis, the strongest associations with the total PREVESMED score emerged for physical activity, extra virgin olive oil use, and fruit/vegetable consumption, whereas daily alcohol intake showed the weakest correlation. The multivariable linear regression highlighted higher education, lower BMI, nonsmoking status, higher WHO-5 scores, and older age as significant predictors of better adherence. Exploratory factor analysis identified five factors explaining 59.32% of the total variance.
Conclusion: Our findings suggest that the PREVESMED questionnaire is a promising, multidimensional tool for evaluating adherence to a Mediterranean lifestyle, demonstrating acceptable reliability and significant associations with key health indicators. Further refinement and extended validation - encompassing test-retest reliability, weighted scoring, and biomarker correlations - will strengthen its applicability across diverse populations.
{"title":"Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle.","authors":"Giuseppe Di Lorenzo, Carlo Buonerba, Raffaele Baio, Eleonora Monteleone, Francesco Passaro, Antonio Tufano, Vittorino Montanaro, Vittorio Riccio, Ilaria Gallo, Francesca Cappuccio, Oriana Strianese, Roberta Zarrella, Anna Buonocore, Federica Monaco, Antonio Verde, Giovanni Riccio, Valentina Izzo, Federica Fortino, Ferdinando Costabile, Luca Scafuri","doi":"10.1159/000543959","DOIUrl":"10.1159/000543959","url":null,"abstract":"<p><strong>Background: </strong>The Mediterranean lifestyle is widely recognized for its role in reducing the risk of chronic diseases, including cardiovascular diseases, type 2 diabetes, and cancer. The PREVESMED questionnaire was developed to evaluate adherence to this lifestyle, integrating dietary and non-dietary behaviors. Unlike existing tools, PREVESMED incorporates underexplored elements such as eating pace, herbal tea consumption, and physical activity, providing a multidimensional approach to lifestyle assessment.</p><p><strong>Methods: </strong>The validation of PREVESMED was carried out as part of a planned interim analysis using data collected from participants in the PREVES-ENERGY survey, a cross-sectional study targeting 1,000 adults aged 18 years and above. To assess the reliability of the PREVESMED scale, internal consistency was evaluated using Cronbach's alpha, ensuring an acceptable level of reliability. To investigate the relationships between lifestyle factors, individual questionnaire items, and adherence to Mediterranean lifestyle according to the PREVESMED scale, a correlation analysis was performed. Additionally, to identify significant predictors of better adherence, a multivariable linear regression model was utilized, highlighting key factors influencing adherence. Finally, an exploratory factor analysis (EFA) was conducted to reveal the underlying structure of the PREVESMED scale, identifying key dimensions and their contributions to the total variance.</p><p><strong>Results: </strong>The cohort analyzed for the preliminary validation of the PREVESMED questionnaire consisted of 268 participants, in line with the protocol's planned sample size. Internal consistency analysis demonstrated acceptable reliability (Cronbach's alpha = 0.628). In the correlation analysis, the strongest associations with the total PREVESMED score emerged for physical activity, extra virgin olive oil use, and fruit/vegetable consumption, whereas daily alcohol intake showed the weakest correlation. The multivariable linear regression highlighted higher education, lower BMI, nonsmoking status, higher WHO-5 scores, and older age as significant predictors of better adherence. Exploratory factor analysis identified five factors explaining 59.32% of the total variance.</p><p><strong>Conclusion: </strong>Our findings suggest that the PREVESMED questionnaire is a promising, multidimensional tool for evaluating adherence to a Mediterranean lifestyle, demonstrating acceptable reliability and significant associations with key health indicators. Further refinement and extended validation - encompassing test-retest reliability, weighted scoring, and biomarker correlations - will strengthen its applicability across diverse populations.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"138-150"},"PeriodicalIF":1.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The objective of this study was to examine the efficacy and safety of pestle needle therapy (PNT) across several prevalent conditions, including insomnia, cervical spondylosis, lumbar disc herniation, and other systemic diseases.
Methods: We searched eight databases (SINOMED, China National Knowledge Infrastructure, Wanfang Data, VIP Database, Google Scholar, PubMed, Embase, and Web of Science) from inception to 31 December 2023, using both subject terms and free-text terms related to "pestle needle" and "randomised controlled trial." Eligible randomised controlled trials (RCTs) that investigated PNT alone or in combination with other therapies were included. Primary outcomes included the overall response rate (ORR) and incidence of adverse events.
Results: A total of 29 RCTs involving 2,614 patients were included. Meta-analysis results showed that, compared with controls, PNT significantly improved ORR in insomnia (odds ratio [OR] = 4.07, 95% confidence interval [CI]: 2.33, 7.09), cervical spondylosis (OR = 4.38, 95% CI: 2.41, 7.97), lumbago and leg pain (OR = 3.32, 95% CI: 1.86, 5.91), and lumbar disc herniation (OR = 1.92, 95% CI: 1.12, 3.29). Regarding cervical spondylosis, the intervention of the observation group was significantly better than that of the control group (Z = 4.84, p < 0.001). In terms of low back pain and leg pain, the intervention of the observation group was significantly better than that of the control group (Z = 4.07, p < 0.001). The intervention of the observation group was significantly better than in the control group in improving the total effective rate of the treatment of lumbar disc herniation (Z = 2.37, p = 0.02).
Conclusion: PNT is a safe and effective treatment modality that can complement or substitute conventional interventions. This systematic review and meta-analysis contributes to the evidence base for acupuncture-related therapies, highlighting the potential of PNT to address both musculoskeletal and neurological conditions, thus offering new clinical options and underscoring the need for large-scale, high-quality RCTs to refine treatment protocols.
{"title":"Systematic Review and Meta-Analysis of Pestle Needle Therapy in Managing Insomnia, Cervical Spondylosis, and Other Systemic Diseases.","authors":"Jiaqi Wang, Yingchao Wang, Shudan Yu, Shujun Li, Ning Liu, Genghui Zhang","doi":"10.1159/000546785","DOIUrl":"10.1159/000546785","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to examine the efficacy and safety of pestle needle therapy (PNT) across several prevalent conditions, including insomnia, cervical spondylosis, lumbar disc herniation, and other systemic diseases.</p><p><strong>Methods: </strong>We searched eight databases (SINOMED, China National Knowledge Infrastructure, Wanfang Data, VIP Database, Google Scholar, PubMed, Embase, and Web of Science) from inception to 31 December 2023, using both subject terms and free-text terms related to \"pestle needle\" and \"randomised controlled trial.\" Eligible randomised controlled trials (RCTs) that investigated PNT alone or in combination with other therapies were included. Primary outcomes included the overall response rate (ORR) and incidence of adverse events.</p><p><strong>Results: </strong>A total of 29 RCTs involving 2,614 patients were included. Meta-analysis results showed that, compared with controls, PNT significantly improved ORR in insomnia (odds ratio [OR] = 4.07, 95% confidence interval [CI]: 2.33, 7.09), cervical spondylosis (OR = 4.38, 95% CI: 2.41, 7.97), lumbago and leg pain (OR = 3.32, 95% CI: 1.86, 5.91), and lumbar disc herniation (OR = 1.92, 95% CI: 1.12, 3.29). Regarding cervical spondylosis, the intervention of the observation group was significantly better than that of the control group (Z = 4.84, p < 0.001). In terms of low back pain and leg pain, the intervention of the observation group was significantly better than that of the control group (Z = 4.07, p < 0.001). The intervention of the observation group was significantly better than in the control group in improving the total effective rate of the treatment of lumbar disc herniation (Z = 2.37, p = 0.02).</p><p><strong>Conclusion: </strong>PNT is a safe and effective treatment modality that can complement or substitute conventional interventions. This systematic review and meta-analysis contributes to the evidence base for acupuncture-related therapies, highlighting the potential of PNT to address both musculoskeletal and neurological conditions, thus offering new clinical options and underscoring the need for large-scale, high-quality RCTs to refine treatment protocols.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"341-353"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144301277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The escalating prevalence and severity of obesity and its associated comorbidities globally necessitate effective interventions. This randomized open-label clinical study aims to assess the efficacy of amla (Emblica officinalis) extract AMX-160 in adult individuals with obesity.
Trial design: This study is a randomized, open-label clinical study conducted at Rajalakshmi Hospital, Mangalore. The study adhered to the declaration of Helsinki and ICH-GCP guidelines, with protocol approval from institutional ethics committee and registration with the Clinical Trials Registry - India (CTRI/2019/01/017201). All participants provided written, signed, and dated informed consent before any study-related procedures.
Methods: Forty obese patients were enrolled and divided into two groups. AMX-160 capsules, at doses of 500 mg once daily (AMX-M1) and twice daily (AMX-M2), were administered. Patients were monitored as outpatients for 90 days. Efficacy assessments included anthropometric measurements, bioelectric impedance analysis, lipid profile analysis, and the Global Physical Activity Questionnaire (GPAQ) at scheduled visits.
Results: Supplementation with 1 g of AMX-160 (500 mg twice daily) significantly (p < 0.05) reduced visceral fat, increased skeletal muscle mass, and decreased subcutaneous fat. Additionally, it effectively decreased body age and various anthropometric parameters (e.g., waist circumference, waist-to-hip ratio) significantly (p < 0.05), along with reducing BMI, body weight, and improving lipid profile (p < 0.05). The 500 mg once daily dose also significantly (p < 0.05) impacted most parameters. Physical activity levels remained consistent in both groups throughout the study (p > 0.05).
Conclusion: The amla extract AMX-160 (Tri-Low®) demonstrated efficacy in reducing subcutaneous and visceral fat, waist circumference, and body age, while increasing skeletal muscle mass. These findings suggest its potential as a supplement for managing obesity and its associated disorders.
{"title":"Effect of Amla Extract on Body Mass Index, Waist Circumference, Total Body Fat, Visceral Fat, Skeletal Muscle Mass, Body Age, and Related Parameters: A Randomized, Open-Label Clinical Study in Obese Participants.","authors":"Deepa Suhag, Raksha Rathore, Ankia Yadav, Avni Khatkar, Deepa Suhag, Giriraja Kanakapura Vrushabaiah, Suman Govindaraj","doi":"10.1159/000545247","DOIUrl":"10.1159/000545247","url":null,"abstract":"<p><strong>Background: </strong>The escalating prevalence and severity of obesity and its associated comorbidities globally necessitate effective interventions. This randomized open-label clinical study aims to assess the efficacy of amla (Emblica officinalis) extract AMX-160 in adult individuals with obesity.</p><p><strong>Trial design: </strong>This study is a randomized, open-label clinical study conducted at Rajalakshmi Hospital, Mangalore. The study adhered to the declaration of Helsinki and ICH-GCP guidelines, with protocol approval from institutional ethics committee and registration with the Clinical Trials Registry - India (CTRI/2019/01/017201). All participants provided written, signed, and dated informed consent before any study-related procedures.</p><p><strong>Methods: </strong>Forty obese patients were enrolled and divided into two groups. AMX-160 capsules, at doses of 500 mg once daily (AMX-M1) and twice daily (AMX-M2), were administered. Patients were monitored as outpatients for 90 days. Efficacy assessments included anthropometric measurements, bioelectric impedance analysis, lipid profile analysis, and the Global Physical Activity Questionnaire (GPAQ) at scheduled visits.</p><p><strong>Results: </strong>Supplementation with 1 g of AMX-160 (500 mg twice daily) significantly (p < 0.05) reduced visceral fat, increased skeletal muscle mass, and decreased subcutaneous fat. Additionally, it effectively decreased body age and various anthropometric parameters (e.g., waist circumference, waist-to-hip ratio) significantly (p < 0.05), along with reducing BMI, body weight, and improving lipid profile (p < 0.05). The 500 mg once daily dose also significantly (p < 0.05) impacted most parameters. Physical activity levels remained consistent in both groups throughout the study (p > 0.05).</p><p><strong>Conclusion: </strong>The amla extract AMX-160 (Tri-Low®) demonstrated efficacy in reducing subcutaneous and visceral fat, waist circumference, and body age, while increasing skeletal muscle mass. These findings suggest its potential as a supplement for managing obesity and its associated disorders.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"326-340"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143969099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-04DOI: 10.1159/000547567
William W N Tsang, Yuen Ting Wong, Joshua S H Tsang
Introduction: The aim of this study was to investigate the effects of 3 months of seated Tai Chi (TC) practice on the eye-hand coordination and sitting balance control of subjects with Parkinson's disease.
Method: A prospective non-randomized study was conducted with 29 subjects practicing TC and 27 subjects as controls according to their preference. The seated TC group underwent 3 months of training with a total of 24 sessions (1 h/session, 2 sessions/week). The outcome measures included a dynamic finger-pointing task (reaction time, movement time, and accuracy), and a sequential weight-shifting balance control test (completion time) while seated.
Results: The TC group showed faster movement time in the dynamic finger-pointing task (p = 0.003). They also achieved a faster completion time of the sequential weight-shifting balance test (p = 0.021). No significant difference was observed in the control group.
Conclusions: The results demonstrate that 3 months of seated TC training could improve movement time in the finger-pointing task and sitting balance control in subjects with Parkinson's disease. A future randomized controlled trial is warranted.
{"title":"Seated Tai Chi Improves Dynamic Finger-Pointing Task and Sitting Balance Control in Subjects with Parkinson's Disease: A Prospective Comparative Observational Study.","authors":"William W N Tsang, Yuen Ting Wong, Joshua S H Tsang","doi":"10.1159/000547567","DOIUrl":"10.1159/000547567","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to investigate the effects of 3 months of seated Tai Chi (TC) practice on the eye-hand coordination and sitting balance control of subjects with Parkinson's disease.</p><p><strong>Method: </strong>A prospective non-randomized study was conducted with 29 subjects practicing TC and 27 subjects as controls according to their preference. The seated TC group underwent 3 months of training with a total of 24 sessions (1 h/session, 2 sessions/week). The outcome measures included a dynamic finger-pointing task (reaction time, movement time, and accuracy), and a sequential weight-shifting balance control test (completion time) while seated.</p><p><strong>Results: </strong>The TC group showed faster movement time in the dynamic finger-pointing task (p = 0.003). They also achieved a faster completion time of the sequential weight-shifting balance test (p = 0.021). No significant difference was observed in the control group.</p><p><strong>Conclusions: </strong>The results demonstrate that 3 months of seated TC training could improve movement time in the finger-pointing task and sitting balance control in subjects with Parkinson's disease. A future randomized controlled trial is warranted.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"273-282"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-07-02DOI: 10.1159/000547181
Jozélio Freire de Carvalho, Aaron Lerner, Carina Benzvi
Background: Garlic and garlic extract (GE) are highly consumed traditional and popular food spices. They are reported to have antioxidant, anti-inflammatory, and infection-protecting properties. The aim of this study was to review the use of GE in various rheumatic diseases.
Summary: PubMed/MEDLINE, Embase, and SciELO were searched for articles on GE and rheumatic diseases between 1966 and May 2024. Four articles were found, including 176 patients. The investigated diseases were rheumatoid arthritis (RA) (n = 3) and osteoarthritis (OA) (n = 1). Age varied from 51.06 ± 13.8 to 58.9 ± 7.5 years old, and female gender was the only one included in all studies. The disease duration was 6.58 ± 7.75 years. The GE dosage ranged from 600 mg to 1,000 mg/day. The follow-up ranged from 4 to 12 weeks. All articles demonstrated improvements in the diverse rheumatic disease parameters (e.g., pain, function, disease activity, tender and swollen joints, stiffness, and WOMAC) and reduced inflammatory biomarkers (C-reactive protein, tumor necrosis factor, malondialdehyde).
Key messages: GE is a safe and well-tolerated therapy for RA and OA. However, studies with more participants are needed to confirm, replicate, and further explore the topic.
{"title":"Garlic Extract in Rheumatological Diseases: A Systematic Review.","authors":"Jozélio Freire de Carvalho, Aaron Lerner, Carina Benzvi","doi":"10.1159/000547181","DOIUrl":"10.1159/000547181","url":null,"abstract":"<p><strong>Background: </strong>Garlic and garlic extract (GE) are highly consumed traditional and popular food spices. They are reported to have antioxidant, anti-inflammatory, and infection-protecting properties. The aim of this study was to review the use of GE in various rheumatic diseases.</p><p><strong>Summary: </strong>PubMed/MEDLINE, Embase, and SciELO were searched for articles on GE and rheumatic diseases between 1966 and May 2024. Four articles were found, including 176 patients. The investigated diseases were rheumatoid arthritis (RA) (n = 3) and osteoarthritis (OA) (n = 1). Age varied from 51.06 ± 13.8 to 58.9 ± 7.5 years old, and female gender was the only one included in all studies. The disease duration was 6.58 ± 7.75 years. The GE dosage ranged from 600 mg to 1,000 mg/day. The follow-up ranged from 4 to 12 weeks. All articles demonstrated improvements in the diverse rheumatic disease parameters (e.g., pain, function, disease activity, tender and swollen joints, stiffness, and WOMAC) and reduced inflammatory biomarkers (C-reactive protein, tumor necrosis factor, malondialdehyde).</p><p><strong>Key messages: </strong>GE is a safe and well-tolerated therapy for RA and OA. However, studies with more participants are needed to confirm, replicate, and further explore the topic.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"296-300"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-01DOI: 10.1159/000547403
Silin Ou, Ming Dong, Ying Wei, Hongmei Huan, Wenqian Wang
Background: With a wide range of clinical needs, evidence-based support for acupuncture therapy through clinical trials is essential for enhancing its scientific value, clinical application, and international influence.
Objective: The aim of this study was to provide design ideas and specific methodology references for acupuncturists and researchers for the design, implementation, and publication of high-level acupuncture clinical research.
Data sources: The data came from PubMed, Web of Science, and EBSCO databases since its inception until February 28, 2024. A total of 89 articles were retrieved, and the primary interventions were manual acupuncture, electroacupuncture, auricular acupuncture, and laser acupuncture. Eighty-five clinical trials on manual acupuncture and electroacupuncture as primary interventions were included.
Results: All of the high-quality clinical trial publications on acupuncture included in the review adhered to the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA). They demonstrated rigor and accuracy in trial design selection, inclusion criteria development, sample size calculations, and statistical methodology, and provided clear, concise details of acupuncture interventions and control settings.
Conclusion: These trials have elevated the overall quality of the research and provided invaluable insights and methodological frameworks for designing randomized controlled trials (RCTs) in acupuncture. Despite these advancements, several limitations remain that warrant attention in future endeavors. Addressing these shortcomings is crucial for enhancing the methodological rigor and reliability of acupuncture trials and advancing evidence-based practice in this field.
背景:针灸治疗具有广泛的临床需求,通过临床试验为针灸疗法提供循证支持是提高其科学价值、临床应用和国际影响力的必要条件。目的:为针灸师和科研人员设计、实施和发表高水平针灸临床研究提供设计思路和具体方法论参考。数据来源:数据来自Pubmed, Web of Science和EBSCO数据库,从成立到2024年2月28日。共检索到91篇文献,主要干预措施为手针、电针、耳针和激光针。纳入85项以手针和电针为主要干预措施的临床试验。结果:纳入本综述的所有高质量的针灸临床试验出版物均遵守试验综合报告标准(CONSORT)声明和针灸临床试验干预措施报告标准(STRICTA)。他们在试验设计选择、纳入标准制定、样本量计算、统计方法方面表现出严谨性和准确性,并提供了针灸干预和对照设置的清晰、简明的细节。结论:这些试验提高了研究的整体质量,并为设计针灸随机对照试验(rct)提供了宝贵的见解和方法框架。尽管取得了这些进步,但仍存在一些限制,值得在未来的努力中加以注意。解决这些缺点对于提高针灸试验方法的严谨性和可靠性以及推进该领域的循证实践至关重要。
{"title":"Commonality Analysis of High-Quality Acupuncture Clinical Trial Articles.","authors":"Silin Ou, Ming Dong, Ying Wei, Hongmei Huan, Wenqian Wang","doi":"10.1159/000547403","DOIUrl":"10.1159/000547403","url":null,"abstract":"<p><strong>Background: </strong>With a wide range of clinical needs, evidence-based support for acupuncture therapy through clinical trials is essential for enhancing its scientific value, clinical application, and international influence.</p><p><strong>Objective: </strong>The aim of this study was to provide design ideas and specific methodology references for acupuncturists and researchers for the design, implementation, and publication of high-level acupuncture clinical research.</p><p><strong>Data sources: </strong>The data came from PubMed, Web of Science, and EBSCO databases since its inception until February 28, 2024. A total of 89 articles were retrieved, and the primary interventions were manual acupuncture, electroacupuncture, auricular acupuncture, and laser acupuncture. Eighty-five clinical trials on manual acupuncture and electroacupuncture as primary interventions were included.</p><p><strong>Results: </strong>All of the high-quality clinical trial publications on acupuncture included in the review adhered to the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA). They demonstrated rigor and accuracy in trial design selection, inclusion criteria development, sample size calculations, and statistical methodology, and provided clear, concise details of acupuncture interventions and control settings.</p><p><strong>Conclusion: </strong>These trials have elevated the overall quality of the research and provided invaluable insights and methodological frameworks for designing randomized controlled trials (RCTs) in acupuncture. Despite these advancements, several limitations remain that warrant attention in future endeavors. Addressing these shortcomings is crucial for enhancing the methodological rigor and reliability of acupuncture trials and advancing evidence-based practice in this field.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"314-325"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144945755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-10-14DOI: 10.1159/000548880
Hiroshi Kondo, Erika Matsuda, Shingo Ogawa, Hiroshi Nishimura, Akira Ono
Background: Home healthcare massage is widely used in Japan under insurance coverage, yet scientific evidence on its effectiveness and adverse events remains limited.
Objective: The aims of the study were to examine effectiveness and predictors of improvement in disabled older adults receiving home healthcare massage and to describe adverse events.
Methods: A retrospective cohort study included 469 participants (mean age 80.2 years; 65.7% women) from 10 clinics. Outcomes at baseline and 1 year were the level of nursing care required, the degree of independent living, and 15 basic activities of daily living. Participants were classified as improved, unchanged, or worsened. Logistic regression identified predictors of improvement. Adverse events during 1 year were recorded.
Results: Improvement was associated with a mild level of nursing care required at baseline (OR = 0.865), muscle atrophy (OR = 1.87), and no use of services other than massage (OR = 0.439). Maintenance without deterioration was also considered clinically meaningful. Ninety-six adverse events (20.5%) were reported, most frequently pain, followed by abrasions/contusions/bruises and numbness. Severity, causality, and temporal course were not collected.
Conclusion: Home healthcare massage may contribute to functional improvement under specific conditions, though most participants received combination therapies. These findings reflect real-world practice in Japan and support the need for large-scale prospective studies.
{"title":"Home Healthcare Massage for Disabled Older Adults in Japan: Factors Associated with Improvement and Adverse Events.","authors":"Hiroshi Kondo, Erika Matsuda, Shingo Ogawa, Hiroshi Nishimura, Akira Ono","doi":"10.1159/000548880","DOIUrl":"10.1159/000548880","url":null,"abstract":"<p><strong>Background: </strong>Home healthcare massage is widely used in Japan under insurance coverage, yet scientific evidence on its effectiveness and adverse events remains limited.</p><p><strong>Objective: </strong>The aims of the study were to examine effectiveness and predictors of improvement in disabled older adults receiving home healthcare massage and to describe adverse events.</p><p><strong>Methods: </strong>A retrospective cohort study included 469 participants (mean age 80.2 years; 65.7% women) from 10 clinics. Outcomes at baseline and 1 year were the level of nursing care required, the degree of independent living, and 15 basic activities of daily living. Participants were classified as improved, unchanged, or worsened. Logistic regression identified predictors of improvement. Adverse events during 1 year were recorded.</p><p><strong>Results: </strong>Improvement was associated with a mild level of nursing care required at baseline (OR = 0.865), muscle atrophy (OR = 1.87), and no use of services other than massage (OR = 0.439). Maintenance without deterioration was also considered clinically meaningful. Ninety-six adverse events (20.5%) were reported, most frequently pain, followed by abrasions/contusions/bruises and numbness. Severity, causality, and temporal course were not collected.</p><p><strong>Conclusion: </strong>Home healthcare massage may contribute to functional improvement under specific conditions, though most participants received combination therapies. These findings reflect real-world practice in Japan and support the need for large-scale prospective studies.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"463-473"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145291388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Trigeminal herpetic neuralgia, a common type of Zoster-associated pain (ZAP), affects individuals across all ages groups and poses a significant societal burden all over the world. Electroacupuncture (EA) is increasingly used in the treatment of ZAP due to its affordability, high safety profile, absence of adverse reactions, and high patient acceptance. Consequently, it is essential to conduct randomized controlled trials to evaluate the effectiveness and safety of EA in treating ZAP and to determine if EA can be used as an alternative to pregabalin.
Patients and methods: A total of 102 patients with trigeminal herpetic neuralgia will be enrolled from 2 hospitals and randomly assigned to the EA group, pregabalin group, or EA + pregabalin group in a 1:1:1 ratio using a simple random number table. The study will consist of a 4-week treatment period followed by a 4-week follow-up period. The primary outcome measure will be pain intensity, while secondary outcomes will include mood state, sleep quality, and quality of life. Adverse reactions will be thoroughly evaluated.
Conclusion: This study aims to elucidate the clinical effectiveness of EA combined with pregabalin for trigeminal herpetic neuralgia and to objectively compare the effectiveness and safety of EA versus oral pregabalin in the treatment of trigeminal herpetic neuralgia.
{"title":"Effectiveness of Electroacupuncture Combined with Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: A Multicenter Randomized Controlled Trial Study Protocol.","authors":"Shimin Li, Xilong Yang, Yunfan Xia, Yunyan Shen, Jingfang Li, Chengcheng Kong, Hui Wang, Ruohan Sun, Zhiyuan Bian, Zuyong Zhang, Jianqiao Fang, Ping Lin","doi":"10.1159/000549320","DOIUrl":"10.1159/000549320","url":null,"abstract":"<p><strong>Background: </strong>Trigeminal herpetic neuralgia, a common type of Zoster-associated pain (ZAP), affects individuals across all ages groups and poses a significant societal burden all over the world. Electroacupuncture (EA) is increasingly used in the treatment of ZAP due to its affordability, high safety profile, absence of adverse reactions, and high patient acceptance. Consequently, it is essential to conduct randomized controlled trials to evaluate the effectiveness and safety of EA in treating ZAP and to determine if EA can be used as an alternative to pregabalin.</p><p><strong>Patients and methods: </strong>A total of 102 patients with trigeminal herpetic neuralgia will be enrolled from 2 hospitals and randomly assigned to the EA group, pregabalin group, or EA + pregabalin group in a 1:1:1 ratio using a simple random number table. The study will consist of a 4-week treatment period followed by a 4-week follow-up period. The primary outcome measure will be pain intensity, while secondary outcomes will include mood state, sleep quality, and quality of life. Adverse reactions will be thoroughly evaluated.</p><p><strong>Conclusion: </strong>This study aims to elucidate the clinical effectiveness of EA combined with pregabalin for trigeminal herpetic neuralgia and to objectively compare the effectiveness and safety of EA versus oral pregabalin in the treatment of trigeminal herpetic neuralgia.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"485-494"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}